Research output per year
Research output per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial
Kievit, H., Muntinghe-Wagenaar, M. B., Hijmering-Kappelle, L. B. M., Hiddinga, B. I., Ubbels, J. F., Wijsman, R., Slingers, G., de Vries, R., Groen, H. J. M., Kerstjens, H. A. M., van der Wekken, A. J. & Hiltermann, T. J. N., 7-Feb-2023, (E-pub ahead of print) In: Lung Cancer. 178, p. 96-102 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
The additional diagnostic value of virtual bronchoscopy navigation in patients with pulmonary nodules: The NAVIGATOR study
Hiddinga, B. I., Slebos, D-J., David Koster, T., Hijmering-Kappelle, L. B. M., Hiltermann, T. J. N., Kievit, H., van der Wekken, A. J., de Jonge, G., Vliegenthart, R., Van De Wauwer, C., Timens, W. & Bensch, F., Mar-2023, In: Lung Cancer. 177, p. 37-43 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature
Koopman, B., Groen, H. J. M., Schuuring, E., Hiltermann, J., Timens, W., den Dunnen, W. F. A., van den Berg, A., ter Elst, A., van Kruchten, M., Kluiver, J., Hiddinga, B., Hijmering-Kappelle, L., Groves, M., Vilachá Madeira R Santos, J., van Kempen, L. & van der Wekken, A. J., Mar-2022, In: Clinical lung cancer. 23, 2, p. e104-e115 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Citations (Scopus)45 Downloads (Pure) -
Are anaplastic lymphoma kinase (ALK) and O6-methylguanine- DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)?
Hiddinga, B., Zwaenepoel, K., Janssens, A., Van Meerbeeck, J. & Pauwels, P., 2022, In: Oncotarget. 13, p. 800-809 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.
van der Leest, P., Hiddinga, B., Miedema, A., Azpurua, A. M. L., Rifaela, N., ter Elst, A., Timens, W., Groen, H. J. M., van Kempen, L. C. & Hiltermann, T. J. N., Jan-2022, In: Molecular oncology. 16, 1, p. 310-310 1 p.Research output: Contribution to journal › Erratum
Open AccessFile27 Downloads (Pure)